Top Markets
#1 Gama Token Gama Token +9.13%
#2 Audiera Audiera +4.96%
#3 Akedo Akedo +4.75%
#4 Nexpace Nexpace +4.13%
#5 Cross Cross +3.76%
#6 Ontology Gas Ontology Gas +3.64%
#7 Holoworld Holoworld +3.39%
#8 Velvet Velvet +3.01%
#9 Humanity Humanity +2.82%
#10 Perle Perle +2.77%
Coin of the day
Gama Token Gama Token
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Carmell Therapeutics Corporation Carmell Therapeutics Corporation

Carmell Therapeutics Corporation

CTCX
Classement en actions #36666
Carmell Therapeutics Corporation (CTCX) specializes in the creation of... Carmell Therapeutics Corporation (CTCX) specializes in the creation of plasma-based bioactive materials (PBMs) aimed at catalyzing tissue regeneration and repair following injury, illness, or the effects of aging. Their flagship product, CT-101, is a versatile accelerant with a dual focus. For orthopedic and dental applications, it's designed to enhance bone healing in cases such as tibia fractures, foot and ankle fusions, spinal fusions, and also serves as a dental bone graft substitute and bone void filler. Furthermore, CT-101 acts as a tissue healing accelerant, addressing conditions like androgenetic alopecia (pattern baldness) and persistent chronic wounds. Established in 2008, the company operates from its headquarters in Pittsburgh, Pennsylvania.
Prix de l'action
$0.117
Dernière synchronisation: 2025-04-04
Capitalisation boursière
$2.45M
Changement (1 jour)
-13.59%
Changement (1 an)
0.00%
Pays
US
Échange Carmell Therapeutics Corporation (CTCX)

Catégorie

Healthcare
Ratio P/B pour Carmell Therapeutics Corporation (CTCX)
Ratio P/B au August 2026 TTM : -0.06
Selon les derniers rapports financiers et le cours de l'action de Carmell Therapeutics Corporation, le ratio cours/valeur comptable actuel (TTM) est -0.06. À la fin de 2023, le ratio P/B était de 95.93.
Historique du ratio P/B pour Carmell Therapeutics Corporation de 2021 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
2026 (TTM) -0.06 -99.85%
2024 -37.13 -138.70%
2023 95.93 -161.62%
2022 -155.68 -19.29%
2021 -192.90 0.00%
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -11,404.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -11,225.31%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 -6,269.70%
BE